Publications by authors named "Xuwen Mao"

Claim this Profile
H
Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway.
Yuche Wu, Bing Wang, Xuwen Mao, Wei Chen, Haji Akber Aisa

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway.
Yuche Wu, Bing Wang, Xuwen Mao, Wei Chen, Haji Akber Aisa

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic study on the restoration of intestinal barrier integrity and alleviation of inflammatory bowel disease by rhynchophylline via the AhR-NR4A1 pathway.
Xuwen Mao, Lufeng Cheng, Yu Liu, Yuche Wu

Front Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice.
XuWen Mao, Guliruoyi Paerhati, Yuche Wu, Lu Feng Cheng

Front Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis